Page 138 - 202004

016-0764-6. 1079.
[11] VAN TONDER E，HERSELMAN MG，VISSER J. The [23] KLEIN EA，THOMPSON IJ，TANGEN CM，et al. Vita-
prevalence of dietary-related complementary and alterna- min E and the risk of prostate cancer：the selenium and vi-
tive therapies and their perceived usefulness among can- tamine cancer prevention trial（SELECT）[J]. JAMA，2011，
cer patients [J]. J Hum Nutr Diet，2009，22（6）：528-535. 306（1）：1549-1556.
[12] VALJI R，ADAMS D，VOHRA S. Complementary and al- [24] SULLIVAN A，GILBAR P，CURTAIN C. Complementary
ternative medicine：a survey of its use in pediatric oncolo- and alternative medicine use in cancer patients in rural
gy[J]. Evid Based Complement Alternat Med，2013. DOI： Australia[J]. Integr Cancer Ther，2015，14（4）：350-358.
10.1155/2013/527163. [25] GOTTSCHLING S，MEYER S，GROWALD B. Differenc-
[13] DHANOA A，YONG TL，YEAP SJ，et al. Complementary es in use of complementary and alternative medicine be-
and alternative medicine use amongst Malaysian orthopae- tween children and adolescents with cancer in Germany：a
dic oncology patients[J]. BMC Complement Altern Med， population based survey[J]. Pediatr Blood Cancer，2013，
2014. DOI：10.1186/1472-6882-14-404. 61（3）：488－492.
[14] ARENTZ S，SMITH CA，ABBOTT J，et al. Nutritional [26] WU HJ，TAI CJ，CHIEN LY. Symptom severity，symptom
supplements and herbal medicines for women with poly- interference and use of complementary and alternative
cystic ovary syndrome：a systematic review and meta-anal- medicine among survivors of colorectal and breast cancer
ysis[J]. BMC Complement Altern Med，2017. DOI：10. after curative treatment in Taiwan[J]. Eur J Cancer Care，
1186/s12906-017-2011-x. 2019，28（1）：1-10.
[15] TIAN H，QIN W，WU W，et al. Effects of traditional Chi- [27] BREMS C，BARNETT J，JOHNSON ME. Alternative and
nese medicine on chemotherapy：induced myelosuppres- complementary treatment needs and experiences of wom-
sion and febrile neutropenia in breast cancer patients[J]. en with breast cancer[J]. J Altern Complement Med，2013，
Evid Based Complement Alternat Med，2015. DOI：10. 19（7）：657-663.
1155/2015/736197. [28] MUELLER CM，MAI PL，GREENE MH. Complementary
[16] NAJA F，FADEL RA，TFAYLI A. Complementary and al- and alternative medicine use among women at increased
ternative medicine use and its association with quality of genetic risk of breast and ovarian cancer[J]. BMC Comple-
life among Lebanese breast cancer patients：a cross-sec- ment Altern Med，2008. DOI：10.1186/1472-6882-8-17.
tional study[J]. BMC Complement Altern Med，2015. DOI： [29] ABUELGASIM KA，ALSHARHAN Y，JAZIEH AR. The
10.1186/s12906-015-0969-9. use of complementary and alternative medicine by pa-
[17] MATTHEWS AK，SELLERGREN SA，FLEMING G. tients with cancer：a cross-sectional survey in Saudi Ara-
Complementary and alternative medicine use among bia[J]. BMC Complement Altern Med，2018. DOI：10.1016/
breast cancer survivors[J]. J Altern Complement Med， j.ctcp.2010.12.003.
2007，13（5）：555-562. [30] OYUNCHIMEG B，HWANG JH，HAN D. Complementa-
[18] CLEMENT YN，MAHASE V，MOHAMMED C. Herbal ry and alternative medicine use among patients with can-
remedies and functional foods used by cancer patients at- cer in Mongolia：a national hospital survey[J]. BMC Com-
tending specialty oncology clinics in Trinidad[J]. BMC plement Altern Med，2017. DOI：10.1186/s12906-017-
Complement Altern Med，2016. DOI：10.1186/s12906- 1576-6.
016-1380-x. [31] CHANG KH，BRODIE R，KERIN MJ. Complementary
[19] PANTUCK AJ，LEPPERT JT，ZOMORODIAN N. et al. and alternative medicine use in oncology：a questionnaire
Phase Ⅱ study of pomegranate juice for men with rising survey of patients and health care professionals[J]. BMC
prostate-specific antigen following surgery or radiation Cancer，2011. DOI：10.1186/1471-2407-11-196.
for prostate cancer[J]. Clin Cancer Res，2006，12（1）： [32] STUB T，QUANDT SA，KRISTOFFERSEN AE. Comple-
4018-4026. mentary and conventional providers in cancer care experi-
[20] CAO Y，CAO R，BRAKENHIELM E. Antiangiogenic ence of communication with patients and steps to improve
mechanisms of diet-derived polyphenols[J]. J Nutr Bio- communication with other providers[J]. BMC Comple-
chem，2002，13（1）：380-390. ment Altern Med，2017. DOI：10.1186/s12906-017-1814-0.
[21] VLADIMIR S，SERGEY V，NIKOLAI V，et al. The possi- [33] MBIZO J，OKAFOR A，OLAKU O. Complementary and
bility of preventive and therapeutic use of green tea cate- alternative medicine use among persons with multiple
chins in prostate cancer[J]. Anti Cancer Agent Med，2019， chronic conditions：results from the 2012 national health
19（10）：1223-1231. interview survey[J]. BMC Complement Altern Med，2018.
[22] PHILIPPOU Y，HADJIPAVLOU M，KHAN S，et al. DOI：10.1186/s12906-018-2342-2.
Complementary and alternative medicine（CAM）in pros- （收稿日期：2019-04-27 修回日期：2020-01-14）
tate and bladder cancer[J]. BJU Int，2013，112（8）：1073- （编辑：孙 冰）

·512 · China Pharmacy 2020 Vol. 31 No. 4 中国药房 2020年第31卷第4期